Radcliffe Capital Management, L.P. - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 47 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$3,119,294
+47.3%
308,841
+44.6%
0.10%
+94.1%
Q3 2022$2,118,000
+1.3%
213,599
-0.0%
0.05%
+6.2%
Q2 2022$2,091,000
+0.2%
213,6000.0%0.05%
+2.1%
Q1 2022$2,086,000
+7.5%
213,600
+6.8%
0.05%
-7.8%
Q4 2021$1,940,000
-0.3%
200,0000.0%0.05%
-10.5%
Q3 2021$1,946,000
+0.2%
200,0000.0%0.06%
-6.6%
Q2 2021$1,942,000200,0000.06%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Exos Asset Management LLC 45,300$441,0000.23%
MMCAP International Inc. SPC 250,000$2,435,0000.12%
Atalaya Capital Management LP 40,000$386,0000.10%
Radcliffe Capital Management, L.P. 200,000$1,942,0000.06%
Arena Capital Advisors, LLC- CA 75,000$731,0000.06%
FIR TREE CAPITAL MANAGEMENT LP 150,000$1,449,0000.05%
Athanor Capital, LP 147,800$1,428,0000.05%
Woodline Partners LP 275,000$2,654,0000.05%
Ghisallo Capital Management LLC 125,000$1,208,0000.05%
SUVRETTA CAPITAL MANAGEMENT, LLC 300,000$2,922,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders